维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

12篇 您的检索式：作者名="Gootenberg MH"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent non- squamous non-small cell lung cancer 显示文摘	Cohen MH Gootenberg J Keegan P	2007	Oncologist2007，12，6：	1
	2	FDA drug approval summary:pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL)显示文摘	Dinndorf PA Gootenberg J Cohen MH	2007	Oncologist2007，12，：	1
	3	FDA drug approval summary:pegaspargase(oncaspar)for the firstline treatment of children with acute lymphoblastic leukemia(ALL)显示文摘	DINNDORF PA GOOTENBERG J COHEN MH	2007	Oncologist2007，12，8：	1
	4	FDA drug approval summary:Pegasparagase (Oncaspar) for the first-line treatment of children with acurate lymphoblastic leukemia(ALL) 显示文摘	PA Dinndoff J Gootenberg MH Cohen	2007	The on- colcgist2007，12，8：	1
	5	FDA drug approval summary: Bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer 显示文摘	Cohen MH Gootenberg J Keegan P	2007	The Oncologist2007，12，3：	1
	6	FDA drug approval summary:bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer显示文摘	Cohen MH Gootenberg J Keegan P	2007	Oncologist2007，12，3：	1
	7	FDA drugapproval summary: pegaspargase (oncaspar) for the first-linetreatment of children with acute lymphoblastic leukemia (ALL)显示文摘	Dinndorf PA Gootenberg J Cohen MH	2007	Oncologist2007，12，8：	1
	8	FDA drug approv-al summary : pegaspargase ( oncaspar) for the first-line treatmentof children with acute lymphoblastic leukemia ( ALL) 显示文摘	Dinndorf PA Gootenberg J Cohen MH	2007	Oncol-ogist2007，12，8：	1
	9	FDA drug approval sum- mary :pegaspargase ( oncaspar ) for the fist-line, treatment of children with acute lymphoblastic leukemia (ALL) 显示文摘	Dinndorf PA Gootenberg J Cohen MH	2007	Oncologist2007，12，8：	1
	10	FDA drug approval summary: bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer显示文摘	Cohen MH Gootenberg J Keegan P	2007	Oncologist2007，12，3：	1
	11	FDA drug approval summary:bevacizumab (avastin) plus carboplatin and paclitaxel as first- line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer显示文摘	Cohen MH Gootenberg J Keegan P	2007	Oncologist2007，12，6：	1
	12	FDA drug approval summary:bevacizumab(Avastin)plus carboplatin and paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer显示文摘	Cohen MH Gootenberg J Keegan P Pazdur R	2007	Oncologist2007，12，6：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费